ENDURON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Enduron, and when can generic versions of Enduron launch?
Enduron is a drug marketed by Abbvie and Abbott and is included in two NDAs.
The generic ingredient in ENDURON is deserpidine; methyclothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; methyclothiazide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ENDURON?
- What are the global sales for ENDURON?
- What is Average Wholesale Price for ENDURON?
Summary for ENDURON
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 68 |
| Patent Applications: | 4,128 |
| DailyMed Link: | ENDURON at DailyMed |
US Patents and Regulatory Information for ENDURON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | ENDURON | methyclothiazide | TABLET;ORAL | 012524-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbott | ENDURONYL FORTE | deserpidine; methyclothiazide | TABLET;ORAL | 012775-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | ENDURON | methyclothiazide | TABLET;ORAL | 012524-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
